New company to focus on the development of small molecule drug candidates and bio targets to prevent and treat cancer.
Australia-based UniQuest and Emory University, US will oversee the venture raising activities and also work together to raise capital for QUE Oncology. According to the release, QUE Oncology’s first project focus areas include prostate cancer, breast cancer, multiple myeloma, and melanoma. The start up will rely on the resources and infrastructure provided by both institutions, along with advisors in the manufacturing and business fields.
Subscribe to our mailing list, and we'll keep you posted of the latest developments.